General Information of the Compound
Compound ID |
CP0530108
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
10-[(5-bromo-1-methylsulfonylindol-2-yl)methyl]-2-methyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzodiazepine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C27H28BrN5O2S2
|
||||||||||||||||||
Molecular Weight |
598.592
|
||||||||||||||||||
Canonical SMILES |
CN1CCN(CC1)C1=Nc2ccccc2N(Cc2cc3cc(Br)ccc3n2S(C)(=O)=O)c2sc(C)cc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C27H28BrN5O2S2/c1-18-14-22-26(31-12-10-30(2)11-13-31)29-23-6-4-5-7-25(23)32(27(22)36-18)17-21-16-19-15-20(28)8-9-24(19)33(21)37(3,34)35/h4-9,14-16H,10-13,17H2,1-3H3
Show/Hide
|
||||||||||||||||||
InChIKey |
LBFWVTAVUDAKCO-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound